Remidio Innovative Solutions Pvt Ltd

IZ.4
No items found.
No items found.

Remidio Innovative Solutions provides the world's first integrated Diabetic Retinopathy Screening solution that provides an instant report on the presence of Referable Diabetic Retinopathy (RDR) with high accuracy, validated in prospective fieldtrials. The solution includes a CE marked and FDA 510k approved non-mydriatic, smartphone-based imaging device and validated Artificial Intelligence solutions that grades for the presence of RDR, right on the smartphone. The AI algorithmsare CE marked and approved as a Class IIa medical device for use with Remidio Fundus on Phone